Occludin (Marker of Early Blood Brain Barrier Damage) (OCLN/2181), CF568 conjugate, 0.1mg/mL

Catalog number BNC682181-100

Price for BNC682181-100

Size / count 1x 100 µL

About this product

Occludin is a tetraspan integral membrane protein in epithelial and endothelial tight junction (TJ) structures that can contain two extracellular loops. The protein exists in a variety of phosphorylated forms. Phosphorylation is involved in regulating both the localization and the function of Occludin. Expression of Occludin is upregulated by polyunsaturated fatty acids, increasing trans-endothelial cell resistance and reducing cellular permeability to large molecules. The level of Occludin varies greatly depending on tissue; in brain tissue, Occludin is highly expressed at cell-cell contact sites. Non-neural tissues show lower expression and discontinuous distribution. Occludin is a tight junction protein that is a key structural component of the blood-brain barrier (BBB) . Degradation of Occludin is frequently seen in ischemic stroke and contributes to BBB disruption. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications

Catalog number: BNC682181-100
Size / count: 1x 100 µL
Dry ice: No
Hazardous: No
Discontinued: No
CAS Number: 9007-83-4
Synonyms: BLCPMG; Occludin; OCLN; Phosphatase 1 regulatory subunit 115; PTORCH1; Tight junction protein occludin
UNSPSC: 41116161
UNSPSC Description: Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name: OCLN
Gene ID: 100506658
NCBI Gene ID: 592605
UniProt: Q16625
Swiss Prot: Q16625
Host: Mouse
Species Reactivity: Human
Reactivity: Occludin
Immunogen: Recombinant fragment of human Occludin protein (around aa 282-415) (exact sequence is proprietary)
Target Antigen: Occludin
Clonality: Monoclonal
Clone: OCLN/2181
Type: Primary
Source: Animal
Origin: Animal
Applications: IHC, FFPE (verified) |WB (verified)
Positive Control: HepG2 cells. Kidney.
Stability: 2 years
Concentration: 0.1 mg/mL
Buffer: PBS, 0.1% BSA, 0.05% azide
Molecular Weight: 60-82 kDa
Shipping Conditions: RT (ND)
Storage Conditions: Stable at room temperature or 37°C (98°F) for 7 days.
Notes: Protect from light
Shelf Life: Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment: IgG1, kappa
Species: Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.
Classification: 0.05% sodium azide (CAS 26628-22-8)
Conjugate: CF568

Frequently Asked Questions

What is the catalog number for Occludin (Marker of Early Blood Brain Barrier Damage) (OCLN/2181), CF568 conjugate, 0.1mg/mL?

The catalog number for Occludin (Marker of Early Blood Brain Barrier Damage) (OCLN/2181), CF568 conjugate, 0.1mg/mL is BNC682181-100.

What sizes are available for Occludin (Marker of Early Blood Brain Barrier Damage) (OCLN/2181), CF568 conjugate, 0.1mg/mL?

Occludin (Marker of Early Blood Brain Barrier Damage) (OCLN/2181), CF568 conjugate, 0.1mg/mL is available in the following size(s): 1x 100 µL.

Is Occludin (Marker of Early Blood Brain Barrier Damage) (OCLN/2181), CF568 conjugate, 0.1mg/mL in stock?

Occludin (Marker of Early Blood Brain Barrier Damage) (OCLN/2181), CF568 conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures Occludin (Marker of Early Blood Brain Barrier Damage) (OCLN/2181), CF568 conjugate, 0.1mg/mL?

Occludin (Marker of Early Blood Brain Barrier Damage) (OCLN/2181), CF568 conjugate, 0.1mg/mL is manufactured by Biotium.

What is the estimated delivery time for Occludin (Marker of Early Blood Brain Barrier Damage) (OCLN/2181), CF568 conjugate, 0.1mg/mL?

Estimated delivery time for Occludin (Marker of Early Blood Brain Barrier Damage) (OCLN/2181), CF568 conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for Occludin (Marker of Early Blood Brain Barrier Damage) (OCLN/2181), CF568 conjugate, 0.1mg/mL?

The safety data sheet for Occludin (Marker of Early Blood Brain Barrier Damage) (OCLN/2181), CF568 conjugate, 0.1mg/mL is available here: https://cdn.gentaur.com/products/37/68dd02b8061270361e10c353/msds/bnc682181-100.pdf.

What is Occludin (Marker of Early Blood Brain Barrier Damage) (OCLN/2181), CF568 conjugate, 0.1mg/mL used for?

Is this kit compatible with automated liquid handling platforms?

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

What applications has this product been validated for?

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

How do I reconstitute this lyophilized product?

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.